157748 people have viewed this drug in the last 60 days
Updated 2025-10-03
| Last Update | 2022-08-31 |
| Register Year | 2015 |
| Product Type | Human |
| Drug Type | NCE |
| Scientific Name | TRASTUZUMAB EMTANSINE |
| Trade Name | KADCYLA 100 mg powder for concentrate for solution for infusion |
| Strength Unit | mg |
| Pharmaceutical Form | Powder for concentrate for solution for infusion |
| Administration Route | Intravenous use |
| Atc Code1 | L01XC03 |
| Atc Code2 | |
| Size | 0 |
| Size Unit | |
| Package Types | Vial |
| Package Size | 1 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $6084.5 |
| Shelf Life | 36 Months |
| Marketing Company | ROCHE |
| Marketing Country | Switzerland |
| Manufacture Name | Patheon Manufacturing Services LLC |
| Manufacture Country | United States |
| Secondry package manufacture | |
| Main Agent | ALNAGHI COMPANY |
| Secosnd Agent | |
| Third Agent | |
| Visits | 157748 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| KADCYLA 100 mg powder for concentrate fo | $6084.5 | 157748 visits | 2022-08-31 |
| KADCYLA 160 mg powder for concentrate fo | $9735.15 | 272469 visits | 2022-08-31 |